Cargando…

CAR T-Cell Therapy: Adverse Events and Management

Chimeric antigen receptor (CAR) T-cell therapy is an exciting innovation in the treatment of cancer. However, CAR T-cell therapies have been associated with unique adverse events (AEs), including cytokine release syndrome (CRS) and neurologic events (also known as CAR T-cell–related encephalopathy s...

Descripción completa

Detalles Bibliográficos
Autor principal: Adkins, Sherry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521123/
https://www.ncbi.nlm.nih.gov/pubmed/33520343
http://dx.doi.org/10.6004/jadpro.2019.10.4.11